A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment
Phase 3
Recruiting
- Conditions
- Plaque Psoriasis
- Registration Number
- JPRN-jRCT2031230583
- Lead Sponsor
- Shikamura Mitsuhiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
1.Plaque psoriasis for at least 6 months.
2.Moderate to severe disease.
3.Candidate for phototherapy or systemic therapy.
Other protocol defined inclusion criteria apply.
Exclusion Criteria
1.Other forms of psoriasis.
2.History of recent infection.
3.Prior exposure to TAK-279 or active comparator.
Other protocol defined exclusion criteria apply.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method